Connection
Search Results to
This is a "connection" page, showing the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of
Fluticasone propionate pharmacogenetics: CYP3A4*22 polymorphism and pediatric asthma control.
Property | Value |
has minor subject area list
|
Administration, Inhalation; Adolescent; Child; Child, Preschool; Female; Fluticasone; Humans; Male; Pharmacogenetics; Polymorphism, Genetic; Prospective Studies; Surveys and Questionnaires
|
information resource reference
|
Stockmann C, Fassl B, Gaedigk R, Nkoy F, Uchida DA, Monson S, Reilly CA, Leeder JS, Yost GS, Ward RM. Fluticasone propionate pharmacogenetics: CYP3A4*22 polymorphism and pediatric asthma control. J Pediatr. 2013 Jun; 162(6):1222-7, 1227.e1-2.
|
label
|
Fluticasone propionate pharmacogenetics: CYP3A4*22 polymorphism and pediatric asthma control.
|